1. Report Industry Investment Rating The provided content does not mention the industry investment rating. 2. Core Viewpoints of the Report - This week, the pressure of fund selling intensified, and the sold bond types spread from long - term and ultra - long - term interest - rate bonds to credit bonds and Tier 2 capital bonds. The pessimistic sentiment in the bond market spread again, with the 10Y Treasury bond rate smoothly breaking through the key point of 1.80%. Although the bond market sentiment recovered on Friday and funds turned to net buying, the bond market allocation buyers may continue to be absent, and there may still be adjustment space in the bond market, especially for ultra - long - term bonds [9]. - Since August, the growth rate of bond fund scale has been lower than that of stock funds. This week, the issuance share of newly established bond funds remained low, and the net value of various types of bond funds declined significantly, with credit bond funds showing relatively better resistance to decline. Most interest - rate and credit bond funds recorded negative returns in the past three months [90]. 3. Summary According to the Directory 3.1 Overall Sentiment: The Bond Market Vitality Index Declined Significantly - As of September 12, the bond market vitality index decreased by 29 pcts to 22% compared with September 5, and the 5D - MA decreased by 15 pcts to 32%. The rising indicators of bond market vitality included the trading volume of the active 10Y China Development Bank bond / the balance of 9 - 10Y China Development Bank bonds and the excess level of the inter - bank bond market leverage ratio compared with the average of the past 4 years. The declining indicators included the median duration of medium - and long - term pure bond funds, the implied tax rate of the 10 - year China Development Bank bond, and the turnover rate of 30Y Treasury bonds [1][10][12]. 3.2 Institutional Behavior: Funds Sold Heavily, while Rural Commercial Banks and Insurance Companies Strengthened Their Buying 3.2.1 Buying and Selling Strength and Bond Type Selection: Funds Bought Interest - Rate Bonds within 1Y and Sold All Other Types - The net buying strength ranking in the current bond market this week was: large banks > insurance companies > wealth management > other product types > rural finance > others > money market funds > foreign - funded banks. The net selling strength ranking was: funds > city commercial banks > joint - stock banks > securities firms. For ultra - long - term bonds (bonds over 15Y), the net buying strength ranking was: insurance companies > rural commercial banks > wealth management > securities firms > others > other product types, and the net selling strength ranking was: funds > large banks > joint - stock banks > city commercial banks > foreign - funded banks [22]. - From September 8 to 12, the bond market showed different trends each day. Funds mainly sold long - term and ultra - long - term interest - rate bonds, and gradually increased their selling of credit bonds and Tier 2 capital bonds. Rural commercial banks mainly bought long - term and ultra - long - term bonds, and insurance companies' buying strength gradually increased [22][23]. 3.2.2 Trading Portfolio: All Types of Bond Funds Continued to Reduce Duration, with Credit Bond Funds Having a Larger Reduction - As of September 12, the median duration of the full - sample medium - and long - term pure bond funds decreased by 0.11 years compared with September 5. Among them, the median durations of pure interest - rate bond funds, interest - rate bond funds, and credit bond funds decreased by 0.06 years, 0.12 years, and 0.21 years respectively. The median durations of high - performance interest - rate bond funds and credit bond funds decreased by 0.06 years and 0.32 years respectively [42]. 3.2.3 Allocation Portfolio: Wealth Management Extended Duration in the Secondary Market, while Rural Commercial Banks and Insurance Companies Deployed Ultra - Long - Term Bonds - **Differentiated Primary Subscription Demand for Treasury Bonds and Policy - Financial Bonds**: This week, the primary subscription demand for Treasury bonds and policy - financial bonds was differentiated, and the demand for ultra - long - term bonds was also differentiated. The weighted average overall multiples of Treasury bonds and policy - financial bonds changed compared with the previous week [54]. - **Large Banks**: The increase in the supply of ultra - long - term bonds may restrict large banks' ability to buy in the secondary market. In terms of short - term Treasury bonds, large banks increased their net buying of Treasury bonds within 1Y since June, but the cumulative net buying scale this year was still far lower than that of the same period in 2024. The net buying of 1 - 3Y Treasury bonds increased from May to July and decreased in August [58][59]. - **Rural Commercial Banks**: The cumulative net buying scale of rural commercial banks this year was significantly weaker than in previous years, mainly due to the weak net buying of short - term bonds within 1Y. However, the net buying strength of 7 - 10Y and over 10Y bonds was significantly higher than in previous years [71]. - **Insurance Companies**: The net buying strength of insurance companies for bonds this year was significantly higher than in previous years, mainly due to their strong buying of ultra - long - term bonds over 10Y. As of September 12, the ratio of the cumulative net bond buying of insurance companies to the cumulative premium income and the ratio to the cumulative issuance scale of over 10Y government bonds were both slightly higher than at the end of September last year [79]. - **Wealth Management**: Since June, the cumulative net buying scale of wealth management products has continued to rise, and the net buying of bonds over 10Y was particularly strong. This week, the duration of the net - bought bonds in the secondary market remained flat, still at the highest level since February 23, 2024 [85][87]. 3.3 Asset Management Product Tracking: Most Interest - Rate and Credit Bond Funds Recorded Negative Returns in the Past Three Months - Since August, the growth rate of bond fund scale has been lower than that of stock funds. This week, the scale of newly established bond funds was only 27 billion yuan, continuing to decline from the previous week [90]. - This week, the net value of various types of bond funds declined significantly, with credit bond funds showing relatively better resistance to decline. Most interest - rate and credit bond funds recorded negative returns in the past three months [90].

Report Industry Investment Rating No relevant content provided. Core View of the Report The report analyzes the overseas market trends from September 8 to 12, 2025, including the performance of stocks, foreign exchange, bonds, and commodities. It also covers overseas central bank dynamics, Trump policy updates, and high - frequency tracking of the overseas economic fundamentals, and reminds of important events in the coming week. Factors such as economic data, geopolitical situations, and central bank policies have significant impacts on market trends [3]. Summary by Directory 1. Overseas Market One - Week Review - **Equities**: Overseas equities generally rose this week. US stocks' three major indices all closed higher, with the Nasdaq rising for 5 consecutive days. European and Asian major indices also increased due to factors like the increased probability of 3 interest rate cuts within the year. For example, the S&P 500, Dow, and Nasdaq rose 1.59%, 0.95%, and 2.03% respectively; the German DAX and London FTSE 100 rose 0.43% and 0.82%; the Nikkei 225 and South Korean Composite Index rose 4.07% and 5.94% [3][12]. - **Foreign Exchange**: The US dollar weakened this week. The dollar index fell 0.12%. The euro and yen against the dollar changed by +0.15% and - 0.17% respectively, and the RMB against the dollar rose slightly by 0.06% [12]. - **Interest Rates**: The 10Y US Treasury yield declined, while the short - end rose. The 2Y US Treasury rose 5bp, and the 10Y US Treasury fell 4bp. The decline was due to factors consolidating the interest rate cut expectation, and the rise was affected by the Middle - East situation and inflation expectations [13]. - **Commodities**: Gold, crude oil, and copper prices all rose. COMEX gold and silver rose 1.26% and 2.81%; WTI crude oil and copper rose 1.02% and 2.54% [13]. 2. Overseas Policy and Key News 2.1 Overseas Central Bank Dynamics - The market's expectation of a 9 - month interest rate cut by the Fed reached 100%. The core CPI inflation in the US in August met expectations. The market's expectation of a 25bp cut in September was 93.4% (up from 89.0% a week ago), and the probability of a 50bp cut was 6.6% (down from 11.0% a week ago). The probability of a total of 75bp cuts throughout 2025 was 74% (up from 65% a week ago) [4][30][31]. - The Fed's FOMC meeting in September may see increased internal differences, and the new dot - plot may adjust the interest rate cut path significantly and become more decentralized [30]. 2.2 Trump Policy Tracking - **Trade and Tariffs**: The Supreme Court will hold an oral debate on the legality of Trump's global tariff policy in the first week of November. China and the US will hold talks from September 14 - 17 in Spain, discussing issues like US unilateral tariffs and TikTok. China's Ministry of Commerce launched anti - dumping and anti - discrimination investigations on US - imported products. Trump proposed that the EU impose a 100% tariff on Russia's energy buyers (India and China) [33]. - **Fed - related**: Milan may participate in the September FOMC vote. There is a new candidate for the Fed chair, Rick Rieder. The case of Fed governor Cook may have a turn, with evidence to refute the mortgage fraud accusation [33][34]. 3. Overseas Economic Fundamental High - Frequency Tracking 3.1 Overall Economic Outlook - The Polymarket website's bet on a US economic recession in 2025 was 11% (up from 9% a week ago). Bloomberg's consensus forecast for US economic growth in 2025 was revised up to 1.65%, and for the eurozone, it was 1.2% [6][40]. - The New York Fed's Nowcast model slightly lowered the Q3 US real GDP growth forecast to 2.08%, while the Atlanta Fed's GDPNow model raised it to 3.09% [42]. 3.2 Employment - The number of unemployment benefit claimants exceeded expectations, mainly due to the impact in Texas. The initial jobless claims rose to 263,000, with Texas contributing 57%. The number of continuous unemployment benefit claimants remained at 1.939 million [47]. 3.3 Demand - US retail sales were stable, but airport security checks and railway transportation decreased significantly. The red - book retail sales growth rate was 6.6%. Airport security checks fell to 15.787 million, and railway transportation was 468,000 vehicles, with a year - on - year growth rate of - 9.44%. The real - estate market activity picked up, with mortgage rates falling and application indices rising [55]. 3.4 Production - US crude steel production rebounded, and the refinery's capacity utilization rate was stable. The crude steel production in the week ending September 5 was 1.795 million short tons, and the refinery's capacity utilization rate was 94.9% [59]. 3.5 Shipping - International freight rates showed mixed trends. The Drewry World Container Freight Index (WCI) fell 2.9%, while the Baltic Dry Index, Capesize Freight Index, and Panamax Freight Index rose 7.4%, 11.3%, and 8.3% respectively. Chinese port export container prices generally fell, with some routes rising [61][63]. 3.6 Prices - US retail gasoline prices fell 0.69% this week. The 1 - year inflation swap rate was 3.335% (up 0.03 percentage points), and the 2 - year inflation swap rate was 2.906% (down 0.02 percentage points) [65]. 3.7 Financial Conditions - US financial pressure declined. The OFR US Financial Stress Index was - 1.136 (down 0.105 from the previous week), and the CCC high - yield bond credit spread was 8.00% (down from 8.06% a week ago) [67]. 4. Next Week's Overseas Important Event Reminder - Multiple overseas central banks, including the Fed, the Bank of Japan, the Bank of England, and the Bank of Canada, will announce interest rate decisions. Attention should also be paid to US retail data and import price indices. Diplomatic events include China - US trade talks from September 14 - 17 and Trump's state visit to the UK from September 17 - 19 [72].

Investment Rating - Industry Rating: Outperform the market (maintained rating) [9] Core Viewpoints - The report emphasizes the importance of the pig sector, highlighting the expected decline in production capacity due to policy guidance amid strong supply and weak demand conditions [1][2][13] - The dairy and beef sectors are noted for potential recovery, with the beef super cycle possibly starting, and the report suggests focusing on companies with mother cow resources or those adopting a "milk-meat linkage" model [3][15] - The pet sector is experiencing rapid growth of domestic brands and a positive trend in pet food exports, indicating a robust pet economy [3][16] - The poultry sector is advised to focus on the white chicken breeding gap and the marginal improvement in demand for yellow chickens, with recommendations for specific companies [4][17][19] - The planting sector is encouraged to wait for a turnaround in conventional seed industries while emphasizing opportunities in biological breeding [5][21] - The feed sector highlights Hai Da Group as a key recommendation due to its market share increase and consistent performance [6][23] Summary by Sections Pig Sector - Current pig prices are under pressure, with an average price of 13.50 CNY/kg, down 2.67% from the previous week, and the industry is facing a narrowing profit margin [1][13] - The report suggests focusing on undervalued companies with strong profitability, with specific recommendations for leading firms like Muyuan Foods and Wens Foodstuffs [2][14] Beef Sector - The report indicates that the dairy cow capacity reduction is nearing its end, with potential price recovery for raw milk and beef [3][15] - Recommended companies include Youran Dairy and China Shengmu Organic Milk [3][15] Pet Sector - The domestic pet economy is thriving, with significant growth in sales and exports of pet food [3][16] - Key recommendations include Guibao Pet Food and Zhongchong Co., Ltd. [3][16] Poultry Sector - The report highlights the need to focus on the breeding gap for white chickens and the improving demand for yellow chickens [4][17][19] - Recommended companies include Shengnong Development and Lihua Stock [4][17][19] Planting Sector - The report emphasizes the importance of improving yield through advanced breeding techniques and the integration of agricultural practices [5][21] - Key recommendations include Longping High-tech and Dabeinong Technology Group [5][21][22] Feed Sector - Hai Da Group is highlighted as a key player in the feed sector, with expectations of market recovery and increased market share [6][23]

Investment Rating - Industry Rating: Outperform the Market (maintained rating) [5] Core Viewpoints - The Trump administration is considering strict restrictions on medicines from China, which could significantly impact the American pharmaceutical industry and the availability of various treatments [10][11] - The proposed executive order draft includes mandatory reviews of acquisitions by U.S. pharmaceutical companies of experimental drugs from Chinese firms and stricter scrutiny of clinical trial data from China [15][10] - Major pharmaceutical companies like Pfizer and AstraZeneca oppose these restrictions, as they benefit from cost-effective Chinese biotech assets [2][4] - The likelihood of the executive order being enacted is low due to its early discussion stage and the lack of positive feedback [3][5] - Even if the order is implemented, there are various countermeasures available, and the overall impact is expected to be manageable [5] Summary by Sections Section 1: Proposed Restrictions - The draft executive order aims to impose strict controls on Chinese medicines, requiring mandatory reviews for acquisitions and higher scrutiny on clinical data from China [10][15] - The order is seen as a response to concerns about national security and the competitive threat posed by China's biotech sector [11][10] Section 2: Industry Reactions - Major pharmaceutical companies are lobbying against the proposed restrictions, emphasizing the benefits of collaboration with Chinese biotech firms [2][4] - The lobbying efforts highlight a divide between investors tied to the Trump administration and established pharmaceutical companies [10][11] Section 3: Feasibility and Impact - The report suggests that the executive order's implementation is unlikely due to political and practical challenges [3][5] - The pharmaceutical industry is expected to adapt to any potential restrictions, maintaining a focus on global collaboration and innovation [5]

Investment Rating - The investment rating for the company is "Buy" [6] Core Views - The company reported a revenue of 19.514 billion yuan for H1 2025, a year-on-year decrease of 4.63%, primarily due to the impact of drug procurement policies. However, revenue from innovative drugs exceeded 4.3 billion yuan, showing a year-on-year growth of 14.26% [1] - The net profit attributable to the parent company reached 1.702 billion yuan, reflecting a significant year-on-year increase of 38.96%, driven by the sale of remaining equity in Harmony Family and other non-core asset gains [1] - The company has completed two license-out transactions in 2025, indicating a faster-than-expected progress in its innovative drug internationalization efforts [2] - A long-term incentive mechanism has been established, with targets set for net profit and innovative drug revenue, aiming for a compound annual growth rate (CAGR) of approximately 20% from 2025 to 2027 [3] - The subsidiary, Fuhong Hanlin, is making significant progress in clinical trials, which is expected to further enhance the company's performance [4] Financial Forecasts - The revenue forecasts for 2025-2027 have been adjusted to 41.274 billion yuan, 42.496 billion yuan, and 47.572 billion yuan, respectively, while the net profit forecasts have been raised to 3.399 billion yuan, 3.995 billion yuan, and 4.770 billion yuan [5] - The company aims for net profit targets of 3.32 billion yuan, 3.96 billion yuan, and 4.77 billion yuan for 2025-2027, with innovative drug revenue targets of 9.36 billion yuan, 11.23 billion yuan, and 13.48 billion yuan for the same period [3][5]

Investment Rating - Industry Rating: Outperform the market (maintained rating) [5] Core Viewpoints - The focus on "anti-involution" has increased, highlighting investment opportunities in the construction sector. The report suggests four angles to capture these opportunities: 1) "Price elasticity" focusing on benefiting upstream commodities, emphasizing "construction + minerals" and "construction + chemicals" [13][14] 2) Improvement in downstream profitability and capital expenditure, with significant growth in new domestic orders for steel and engineering sectors [14][18] 3) Improvement in financial statements and "transformation and upgrading," with tech-driven construction companies expected to benefit from high demand for tech-based infrastructure [14][15] 4) Related sectors in new energy materials and engineering, particularly in photovoltaic fields [14][15] Summary by Sections Section 1: Investment Opportunities - The report emphasizes the importance of the "anti-involution" theme, with a focus on construction companies that can leverage price elasticity and resource development [13][14] - Specific recommendations include companies like Sichuan Road and Bridge, China Railway, and Shanghai Construction for their resource development capabilities [14][15] Section 2: Market Performance - The construction index rose by 2.16% during the week of September 8-12, outperforming the CSI 300 index by 1.01 percentage points [26] - Notable stock performances included Dongzhu Ecology and Tianyu Ecology, both increasing by 33.05% [26] Section 3: Company-Specific Insights - Sichuan Road and Bridge announced plans to optimize its shareholding structure by introducing strategic investors, aiming to improve its fundamentals [18][19] - The company secured 218 new projects worth approximately 72.2 billion, marking a 22.20% year-on-year increase, with infrastructure orders growing by 25.88% [18][19] Section 4: Construction Material Indicators - The report highlights a significant recovery in the operating rates of petroleum asphalt and cement, indicating a positive trend in physical workload conversion for construction projects [19][24]

Group 1: Davis Double-Click Strategy - The Davis Double-Click strategy involves buying stocks with low price-to-earnings (PE) ratios that have growth potential, and selling them once their growth is realized and PE increases, achieving a multiplier effect on returns [6][9] - The strategy achieved an annualized return of 26.45% during the backtest period from 2010 to 2017, exceeding the benchmark by 21.08% [8] - Year-to-date, the strategy has a cumulative absolute return of 48.70%, outperforming the CSI 500 index by 24.84% [9] Group 2: Net Profit Gap Strategy - The Net Profit Gap strategy focuses on selecting stocks based on fundamental and technical resonance, where "net profit" refers to earnings surprises and "gap" indicates a significant upward price jump on the first trading day after earnings announcements [10] - Since 2010, this strategy has achieved an annualized return of 29.43%, with an annualized excess return of 26.44% [12] - Year-to-date, the strategy has a cumulative absolute return of 53.50%, outperforming the benchmark index by 28.67% [12] Group 3: Enhanced CSI 300 Portfolio - The Enhanced CSI 300 portfolio is constructed based on investor preferences, including GARP, growth, and value investing styles, utilizing PBROE and PEG factors to identify undervalued stocks with strong profitability and growth potential [13] - The portfolio has shown stable excess returns historically, with a year-to-date excess return of 16.31% relative to the CSI 300 index [15] - The strategy's performance this week yielded an excess return of 0.88% [15]

Group 1 - The report indicates that the current WIND All A index is in an upward trend, with the trend line positioned around 6106 points and a positive earning effect of approximately 1.9% [2][10] - The report suggests maintaining a balanced allocation in response to increased market volatility, especially as the market enters a significant event window [2][10] - The report highlights that the market's short-term moving average (20-day) is above the long-term moving average (120-day), with the distance between them increasing from 12.15% to 13.19%, indicating a continued upward trend [2][9] Group 2 - The industry allocation model recommends focusing on sectors that are expected to benefit from policy-driven growth, such as chemicals and innovative new energy, while also continuing to support the Hong Kong innovative pharmaceutical sector [2][10] - The report emphasizes the importance of the market's earning effect in sustaining mid-term incremental capital inflows, as long as the earning effect remains positive [2][10] - The report identifies technology sectors, particularly those related to computing power and batteries, as areas of interest based on the TWO BETA model [2][10]

Investment Rating - The investment rating for the company is "Buy" with a maintained rating for the next six months [8][19]. Core Views - The company's performance in the ready-to-drink segment is expected to drive core earnings, with overall performance anticipated to remain stable throughout the year [2][5]. - The ready-to-drink business has shown a year-on-year growth, while the brewed segment has faced slight pressure [3][5]. - The company is actively seeking transformation, focusing on non-distributor channels, which have shown strong performance [4][5]. Financial Performance Summary - For Q2 2025, the company reported revenues of 4.55 billion, with a year-on-year increase of 0.18%, but a significant increase in losses for net profit and net profit excluding non-recurring items [2][5]. - The revenue breakdown for H1 2025 shows the brewed segment at 4.23 billion (down 31.0% YoY) and the ready-to-drink segment at 5.91 billion (up 8.0% YoY), with the ready-to-drink segment accounting for 58.27% of total revenue [3][5]. - The company's gross margin for Q2 2025 was 27.02%, an increase of 1.31 percentage points YoY, while the net margin was -17.32%, a decrease of 5.23 percentage points YoY [5][12]. Revenue and Profit Forecast - The company expects to achieve net profits of 2.6 billion, 2.8 billion, and 3.0 billion for the years 2025, 2026, and 2027 respectively, reflecting a slight downward adjustment from previous estimates [5][12]. - The projected revenue for 2025 is 3.26 billion, with a growth rate of -0.96% [7][12]. Market Position and Valuation - The company has a total market capitalization of 5.59 billion, with a price-to-earnings ratio of 21.50 for 2025 [9][12]. - The company's earnings per share (EPS) is projected to be 0.63 for 2025, with a steady increase expected in subsequent years [7][12].

固定收益 | 固定收益点评 2025 年 09 月 14 日 作者 谭逸鸣 分析师 SAC 执业证书编号：S1110525050005 tanyiming@tfzq.com 近期报告 1 《固定收益：终端需求仍待提振-高 频跟踪周报 20250913》 2025-09-13 2 《固定收益：流动性跟踪-下周资金 再迎"考验"》 2025-09-13 3 《固定收益：固收点评-社融增速见 顶？》 2025-09-13 固收周度点评 证券研究报告 风浪未平，留一份谨慎 1、本周债市行情回顾：利率再"寻顶" 前半周，债市悲观情绪在基金费率调整的催化之下再度蔓延，以及股债联 动"不对称"、债市"急跌慢涨"的现象仍在延续，前期被认为是 10Y 期国 债利率阶段性顶部的 1.80%点位被顺畅突破。后半周，债市对央行重启买债 的期待升温，利率有所修复。 2、跌势为何加深？承接力量难抵交易盘抛压 刘昱云 分析师 SAC 执业证书编号：S1110525070010 liuyuyun@tfzq.com 唐海清 分析师 SAC 执业证书编号：S1110517030002 tanghaiqing@tfzq.com 藏多 分析师 SA ...